Profile
| Metric | Value |
|---|---|
| Full Name | Glaukos Corporation |
| Ticker | NYSE: GKOS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | glaukos.com |
| Employees | 995 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $110.72 | |
| Price, 1D Change | -1.94% | |
| Market Cap | $6B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.40 | |
| Revenue | $383M | |
| Revenue, 1Y Change | +21.85% | |
| EPS | -$2.77 | |
| EPS, 1Y Change | +0.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$2.77 | |
| EPS Estimate | -$0.83 | |
| EPS Est. Change | +70.13% | |
| Revenue | $383.48M | |
| Revenue Estimate | $493.72M | |
| Revenue Est. Change | +28.75% | |
| Current Price | $110.72 | |
| Price Target | - | $125.00 |
| Price Tgt. Change | - | +12.90% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.19 | -$2.78 | -26.96% | |
| -$1.83 | -$2.77 | -51.24% | |
| -$0.83 | N/A | +70.13% | |
| -$0.33 | N/A | +88.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $311.30M | $314.71M | +1.10% | |
| $378.94M | $383.48M | +1.20% | |
| $493.72M | N/A | +28.75% | |
| $612.13M | N/A | +59.63% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -26.03% | |
| Price, 3Y | +153.48% | |
| Market Cap, 1Y | -24.73% | |
| Market Cap, 3Y | +204.87% | |
| Revenue, 1Y | +21.85% | |
| Revenue, 3Y | +30.43% | |
| EPS, 1Y | +0.21% | |
| EPS, 3Y | -159.72% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $110.72 | |
| SMA 200 | $94.23 | |
| SMA 200 vs Price | -14.89% | |
| SMA 50 | $99.21 | |
| SMA 50 vs Price | -10.40% | |
| Beta | 1.40 | |
| ATR | $3.15 | |
| 14-Day RSI | 54.45 | |
| 10-Day Volatility | 20.86% | |
| 1-Year Volatility | 52.93% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $383.48M | |
| EPS | -$2.77 | |
| Gross Profit | $289.45M | |
| Gross Margin | 75.48% | |
| Operating Profit | -$108.14M | |
| Operating Margin | -28.20% | |
| Net Income | -$146.37M | |
| Net Margin | -38.17% | |
| EBITDA | -$135.56M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 5.99 | |
| Quick Ratio | 5.22 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 13.54 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 13.54 | |
| PB Ratio | 8.26 | |
| EV/EBITDA | -133.78 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $766.93M | |
| Cash & Equivalents | $169.63M | |
| Total Assets | $1.04B | |
| Current Assets | $449.79M | |
| Total Liabilities | $269.22M | |
| Current Liabilities | $75.13M | |
| Total Debt | $105.87M | |
| Short Term Debt | $2.47M | |
| Accounts Payable | $13.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $491.62M | |
| Operating Expenses | $397.59M | |
| Cost Of Goods Sold | $94.03M | |
| SG&A | $261.17M | |
| D&A | $39.92M | |
| Interest Expense | $0.00 | |
| Income Tax | $771.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$61.32M | |
| CFI | $47.83M | |
| CFF | $91.54M | |
| Capex | $6.30M | |
| Free Cash Flow | -$67.62M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stephens & Co. | → | |
| BTIG | → | |
| UBS | → | |
| Truist Securities | → | |
| Citigroup | → | |
| Needham | → | |
| Wells Fargo | → | |
| Needham | → | |
| JP Morgan | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with GKOS
Data Sources & References
- GKOS Official Website www.glaukos.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1192448/000110465925104529/0001104659-25-104529-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1192448/000155837025001402/0001558370-25-001402-index.htm
- GKOS Profile on Yahoo Finance finance.yahoo.com/quote/GKOS
- GKOS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gkos
FAQ
What is the ticker symbol for Glaukos Corporation?
The ticker symbol for Glaukos Corporation is NYSE:GKOS
Does Glaukos Corporation pay dividends?
No, Glaukos Corporation does not pay dividends
What sector is Glaukos Corporation in?
Glaukos Corporation is in the Healthcare sector
What industry is Glaukos Corporation in?
Glaukos Corporation is in the Medical Devices industry
What country is Glaukos Corporation based in?
Glaukos Corporation is headquartered in United States
When did Glaukos Corporation go public?
Glaukos Corporation initial public offering (IPO) was on June 25, 2015
Is Glaukos Corporation in the S&P 500?
No, Glaukos Corporation is not included in the S&P 500 index
Is Glaukos Corporation in the NASDAQ 100?
No, Glaukos Corporation is not included in the NASDAQ 100 index
Is Glaukos Corporation in the Dow Jones?
No, Glaukos Corporation is not included in the Dow Jones index
When was Glaukos Corporation last earnings report?
Glaukos Corporation's most recent earnings report was on October 29, 2025
When does Glaukos Corporation report earnings?
The next expected earnings date for Glaukos Corporation is February 18, 2026